Cough syrup row: Sample testing at designated labs now must for exporters
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
uzbekistan
May 2023
January 2023
December 2022
May 2019
Gambia cough syrup deaths: US FDA issues advisory to drug makers
Advisory comes after deaths were reported from Uzbekistan, Gambia after kids consumed cough syrups with high levels of diethylene glycol and ethylene glycol supplied by Indian manufacturers
Amid Gambia row, Maiden Pharma’s HP plant cough syrups flagged ‘spurious’
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
'Unsafe': WHO issues global alert on Marion Biotech’s cough syrups for kids
WHO says these products are “substandard”, and that their use, especially in children, may result in “serious injury or death”.
Drug regulator shuts Marion Biotech plant, Uzbek cough syrup death probe on
The Central Drugs Standard Control Organisation (CDSCO) has stopped all manufacturing activities at Noida-based Marion Biotech.
India's drug regulator probing Uzbekistan cough syrup death allegations
CDSCO along with UP Drug Control Administration had carried out a joint inspection of Marion's Noida facility, says health minister Mansukh Mandaviya.
Uzbekistan blames India's Marion Biotech cough syrup for 18 child deaths
Uzbekistan is the second country after Gambia to link child deaths to India made cough syrups.
‘Dushanbe is closer to Delhi than Mumbai’
Oxford historian and best-selling author Peter Frankopan talks about globalisation and why India needs to think more about its central Asian neighbours.
